
Clario
Philadelphia, PA, United States clario.com From their website, Nov 2026
Work here? Claim this listing
About
Clario provides clinical trial endpoint technology and evidence generation services for sponsors and research teams. It focuses on cardiac, eCOA, medical imaging, precision motion, and respiratory solutions for clinical trials and healthcare providers, with global delivery.
Services
Cardiac Solutions
Provides cardiac safety and efficacy endpoint solutions for clinical trials across phases and locations.
Arrhythmia Analysis
Collects continuous ECG data in site-based or hybrid trials using flexible solutions and patient-friendly devices.
Blood Pressure Services
Collects and centrally analyzes blood pressure data from site-based to hybrid trials.
ECG – On-site to DCT and Phase I-IV
Monitors ECG data to assess safety and efficacy throughout site-based or hybrid clinical trials.
Phase I/TQT Cardiac Assessment
Supports ICH E14 requirements for early-phase and TQT cardiac assessment.
Regulatory Consultation and Statistical Analysis Expertise
Provides regulatory and statistical analysis support through key opinion leaders.
Clinical Adjudication
Provides clinical endpoint committee support for trial adjudication.
eCOA Clinical Trials
Provides electronic clinical outcome assessment solutions for clinical trials.
22 more services
- eCOA Neuroscience
- eCOA Swift
- eCOA Rapid Start – Assessment Catalog
- eCOA Science Services
- Rater, Participant and Caregiver Training
- Suicidal Ideation Monitoring
- eCOA Rescue Studies
- Medical Imaging
- Medical Imaging Science Team
- Image Redact AI
- Imaging Platform
- SMART Submit
- Precision Motion for Clinical Trials
- Precision Motion for Research
- Respiratory Solutions
- Site-Based Spirometry
- Clinical Trial Data Management
- Clinical Trial Support Service
- Solutions for Healthcare Providers
- Regulatory Consultation and Statistical Analysis
- eCOA Swift – Early Phase
- Suicidal Ideation
- Turnaround
- In as little as 2 weeks
- Deploy early phase oncology trials in as little as 2 weeks
Capabilities
- Assays and studies
- ECG
- Blood pressure
- eCOA
- Clinical adjudication
- Imaging core lab
- Spirometry
9 more
- Pulmonary data
- Wearable sensor endpoints
- Arrhythmia analysis
- Blood pressure analysis
- Medical imaging review
- Wearable sensor endpoint measurement
- Cough assessment
- Lung sound assessment
- DLCO
- Scale and capacity
- All phases
- Site-based or hybrid trials
- Phase I-IV
- As little as 2 weeks
- More than 750 scientific publications
- Therapeutic areas
- Cardiology
- CNS
- Oncology
- Respiratory
- Cardiovascular
- Central nervous system
Instruments and platforms
- Opal V2R®
- Opal® System
- Opal V2R
Modalities and species
- Modalities
- Cell therapy
- Species and models
- CT Scans
- Endoscopy
- MRIs
- Opal V2R
- Opal® System
- eC-SSRS
Industries served
- Biotech
- Pharmaceutical
- Clinical research
Details
- Type
- CRO
- Founded
- 2015
- Quality
- 21 CFR Part 11 (SMART Submit de-identified images) · EU GDPR (SMART Submit de-identified images) · ICH E14 (Phase I/TQT cardiac assessment)
- Based in
- Philadelphia, PA, United States
- Serves
- Anywhere in the world, global